From Next year, Motilal Nehru Medical College MBBS Graduates to Receive Degrees from Atal Bihari Vajpayee Medical University

Uttar Pradesh- From next year, MBBS students graduating from the Motilal Nehru Medical College (MLNMC), Prayagraj, will get degrees from Atal Bihari Vajpayee Medical University (ABVMU), Uttar Pradesh. 

On this, MLNMC authorities have confirmed that the change will apply to the batch of MBBS students who will graduate in the academic year 2025.

The decision has been taken to ensure a unified system of medical curriculum and examination in Uttar Pradesh as several medical colleges in the state are affiliated to ABVMU.

Also Read: NEET Counselling for this academic year to begin on July 6 to fill 9703 MBBS, 2,270 BDS seats in UP

In this regard, speaking to HT, Dr Vatsala Mishra the Principal of MLNMC said, two years ago, MLNMC was affiliated with ABVMU and along with it the examinations are also conducted by the university. Therefore, from now onwards MBBS students will receive the degree certificates from ABVMU and along with MBBS students, MS and MD students will also get degrees from the new university as per their respective batches.

Till now the students of MLNMC have been receiving their degrees from King George's Medical University (KGMU) since 2008, formerly known as Chhatrapati Shahuji Maharaj Medical University, Lucknow. However, MLNMC was affiliated with Allahabad University.

Also Read: Atal Bihari Vajpayee Medical University Invites Applications for Entrance exam for MSc Nursing, Nurse practitioner in critical care courses, details

MLNMC admits 200 MBBS students every year, with 127 seats in 20 disciplines of postgraduate studies and 1 seat in one stream of super-specialisation studies in the medical college. After four annual examinations and an internship, the final degree is awarded by the university.

Motilal Nehru Medical College (MLNMC) was established in 1961 and is spread over 101 acres. The Medical College is a government medical college and hospital in Prayagraj, Uttar Pradesh, India. It was established in the memory of Motilal Nehru, the father of Jawaharlal Nehru. Every year the college admits a batch of 200 students into the first year of its MBBS degree course. Among these, 180 students are admitted through state counselling based on UP state rank in National Eligibility-Entrance Test (NEET) and 20 are admitted through all India counselling based on all India rank in NEET conducted by National Testing Agency (NTA).

Also Read: Atal Bihari Vajpayee Medical University Invites Applications For Common Entrance Test for BSc Nursing Admissions, all details here


from Medical News, Health News Latest, Medical News Today - Medical Dialogues | https://ift.tt/paHiyML

Comments

Post a Comment

Popular posts from this blog

'Details sought include Third-party info, hence exempted under RTI Act': NMC on RTI query on Faculty Gap in Medical Colleges

Image
New Delhi:  Stating that the details sought under the RTI includes third-party information, the National Medical Commission (NMC) has refused to disclose the names of the medical colleges that fell short on faculty counts and other teaching infrastructure. Recently activist Dr. KV Babu filed an application under the Right to Information Act seeking the details of the notices issued by the NMC Undergraduate Medical Education Board (UGMEB) to the medical colleges for deficiencies in Clinical Material and staff during the period from 01/01/2023 to 30/04/2024. He also sought to know the details of the fine imposed or the action taken by the NMC UG Board from 01/01/2023 to 30/04/2024. In response, the Apex medical regulatory body in India has said that the concerned information includes third party information. "Since the information sought by you, includes third party information, hence the same is exempted for as per Section 8(1) (j) of the Right to Information Act, 2005," th...
Read more

Zasocitinib therapy highly efficacious for treatment of severe plaque psoriasis: JAMA

Image
A recent study published in the Journal of American Medical Association revealed that Zasocitinib could be a breakthrough in the treatment of moderate to severe plaque psoriasis. Psoriasis is a chronic inflammatory skin condition characterized by red, scaly patches, affects millions throughout the globe. While several treatments exist, the demand for new, effective, and well-tolerated oral therapies remains high. Zasocitinib, a highly selective allosteric tyrosine kinase 2 (TYK2) inhibitor, emerges as a promising candidate to meet this need. This trial was conducted between August 2021 and September 2022 across 55 centers in the US and Canada and found that Zasocitinib not only significantly improved skin clearance in patients but also expressed a favorable safety and tolerability profile. The study enrolled a total of 287 participants aged between 18 and 70 years, each with a Psoriasis Area and Severity Index (PASI) score of 12 or greater, a Physician’s Global Assessment score of 3...
Read more

New wearable laser device may monitor brain blood flow to gauge stroke risk, reports research

Image
Researchers have developed a laser-based device that can be placed on the head to non-invasively monitor changes in brain blood flow and volume. The new device could one day help save lives by offering a direct and simple way to assess stroke risk based on physiological markers rather than indirect markers like lifestyle factors. Strokes occur when blood flow to the brain is blocked or reduced, causing debilitating brain cell damage. With about 15 million people worldwide affected by strokes each year, it is the second leading cause of death and a leading cause of long-term disability. “The lack of a cost-effective and scalable stroke risk assessment system complicates long-term stroke prevention because a physician can’t tell whether a patient’s risk is stable or worsening,” said research team member Simon Mahler, a postdoctoral scholar in Changhuei Yang’s laboratory at the California Institute of Technology. “This new method could help catch early signs of increased stroke risk, w...
Read more